[Glivek in the therapy of some forms of Ph- and bcr/abl-negative myeloproliferative diseases and a myeloproliferative variant of idiopathic hypereosinophilic syndrome]

Authors :: I S, Nemchenko
N D, Khoroshko
A G, Turkina
O Iu, Vinogradova
M A, Sokolova
E M, Abakumov
E A, Semenova
A V, Zakharova
E V, Domracheva
Source :: Terapevticheskii arkhiv. 76(7)
Publication Year :: 2004

Subjects :: Adult
Male
Myeloproliferative Disorders
Fusion Proteins, bcr-abl
Middle Aged
Polymerase Chain Reaction
Piperazines
Eosinophils
Leukocyte Count
Pyrimidines
Treatment Outcome
Benzamides
Hypereosinophilic Syndrome
Imatinib Mesylate
Humans
Philadelphia Chromosome

Tools